Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens

Clinical Lung Cancer

Volumn 10, Issue 2, 2009, Pages 124-129

  Kocak, Mihriban ^a   Ozkan, Alper ^a   Mayadagli, Alpaslan ^a   Parlak, Cem ^b   Bilici, Ahmet ^a,c   Seker, Mesut ^a   Ustaalioglu, Bala Basak Oven ^a   Gumus, Mahmut ^a   Eren, Makbule ^a   Karabulut, Sule Gul ^a   Oruc, Fatih ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Antalya Devlet Hastanesi ^*  (Turkey)

^c Menderes Mah   (Turkey)

Author keywords

Cisplatin; Docetaxel; Esophagitis; Gemcitabine; Lobectomy; Neutropenia

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; GEMCITABINE; RANITIDINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DESQUAMATION; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; HYPEREMIA; INOPERABLE CANCER; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; OTOTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; UREMIA; WEIGHT REDUCTION;

EID: 65349135324     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2009.n.016     Document Type: Article

References (25)

1. American Cancer Society [Web site]. Cancer facts and figures: 2004. Available at: http://www.cancer.org. Accessed: August 10, 2008
2. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non - small-cell lung cancer guideline: Update 2003. J Clin Oncol 2004; 22:330-53.
3. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323:940-5.
4. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83:417-23.
5. Furuse K, Kubota K, Kawahara M, et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group. J Clin Oncol 1995; 13:869-75.
6. Sause W T, Scott C, Taylor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87:198-205.
7. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88:1210-5.
8. Vokes EE, Green MR. Clinical studies in non-small cell lung cancer: the CALGB experience. Cancer Invest 1998; 16:72-9.
9. Sause W, Kolesar P, Taylor S, IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117:358-64.
10. Vokes EE, Herndon JE II, Kelley MJ, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol 2007; 25:1698-704.
11. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992; 326:524-30.
12. Jeremic B, Shibamoto Y, Acimovic L, et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 1995; 13:452-8.
13. Vokes EE, Herndon JE, II, Crawford J, et al. Randomized phase II study of cispl-atin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: Cancer and leukemia group B study 9431. J Clin Oncol 2002; 20:4191-8.
14. Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events. Version 3.0, DCTD, NCI, NIH, DHHS 2003, March 31, 2006. Available at: http://ctep.cancer.gov. Accessed: August 10, 2008
15. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 1999; 17:2692-9.
16. Curran D, Scott C, Langer C, et al. Long-term benefit is observed in a phase III comparison of sequential versus concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003; 22:621 (Abstract 2499).
17. Pierre F, Maurice P, Gilles R, et al. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC) (GLOT-GFPC NPC 95-01 study). Proc Am Soc Clin Oncol 2001; 20:312 (Abstract 1246).
18. Zatloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 2004; 46:87-98.
19. Vokes EE. Optimal therapy for unresectable stage III non-small-cell lung cancer. J Clin Oncol 2005; 23:5853-5.
20. Clamon G, Herndon J, Cooper R, et al. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17:4-11.
21. Akerley W, Herndon JE Jr, Lyss A P, et al. Induction paclitaxel/ carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study-CALGB 9534. Clin Lung Cancer 2005; 7:47-53.
22. Belani C P, Choy H, Bonomi P, et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non - small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 2005; 23:5883-91.
23. Schiller JH, Harrington D, Sandler A, et al. A randomized phase III trial of four chemotherapy regimens in advanced NSCLC. Proc Am Soc Clin Oncol 2000; 19:1a (Abstract 278).
24. Rodriguez J, Pawel J, Pluzanska P, et al. A multicenter, randomized phase III study of docetaxel + cisplatin and docetaxel + carboplatin versus vinorelbine + cisplatin in chemotherapy naïve patients with advanced and metastatic non-small cell lung cancer. Proc Am Soc Clin Oncol 2001; 20:314a (Abstract 1252).
25. Scagliotti BV, De Marinis F, Rinaldi M, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 2001; 20:308a (Abstract 1227).